Cargando…

Reproducibility Evaluation of Urinary Peptide Detection Using CE-MS

In recent years, capillary electrophoresis coupled to mass spectrometry (CE-MS) has been increasingly applied in clinical research especially in the context of chronic and age-associated diseases, such as chronic kidney disease, heart failure and cancer. Biomarkers identified using this technique ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mavrogeorgis, Emmanouil, Mischak, Harald, Latosinska, Agnieszka, Siwy, Justyna, Jankowski, Vera, Jankowski, Joachim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658976/ https://www.ncbi.nlm.nih.gov/pubmed/34885840 http://dx.doi.org/10.3390/molecules26237260

Ejemplares similares

Urinary CE-MS peptide marker pattern for detection of solid tumors
por: Belczacka, Iwona, et al.
Publicado: (2018)

Author Correction: Urinary CE-MS peptide marker pattern for detection of solid tumors
por: Belczacka, Iwona, et al.
Publicado: (2019)

Collagen-Derived Peptides in CKD: A Link to Fibrosis
por: Mavrogeorgis, Emmanouil, et al.
Publicado: (2021)

Exploratory Study Analyzing the Urinary Peptidome of T2DM Patients Suggests Changes in ECM but Also Inflammatory and Metabolic Pathways Following GLP-1R Agonist Treatment
por: Lohia, Sonnal, et al.
Publicado: (2023)

A Novel Urinary Proteomics Classifier for Non-Invasive Evaluation of Interstitial Fibrosis and Tubular Atrophy in Chronic Kidney Disease
por: Catanese, Lorenzo, et al.
Publicado: (2021)

Associations of urinary polymeric immunoglobulin receptor peptides in the context of cardio-renal syndrome
por: He, Tianlin, et al.
Publicado: (2020)

Molecular Mapping of Urinary Complement Peptides in Kidney Diseases
por: Wendt, Ralph, et al.
Publicado: (2021)

Glycosylation Analysis of Urinary Peptidome Highlights IGF2 Glycopeptides in Association with CKD
por: Lohia, Sonnal, et al.
Publicado: (2023)

Proteomic characterization of obesity-related nephropathy
por: Wendt, Ralph, et al.
Publicado: (2020)

Urinary peptides provide information about the risk of mortality across a spectrum of diseases and scenarios
por: Keller, Felix, et al.
Publicado: (2023)

Recent Advances in Urinary Peptide and Proteomic Biomarkers in Chronic Kidney Disease: A Systematic Review
por: Catanese, Lorenzo, et al.
Publicado: (2023)

Urine Peptidome Analysis Identifies Common and Stage-Specific Markers in Early Versus Advanced CKD
por: Hobson, Sam, et al.
Publicado: (2023)

CE–MS-based urinary biomarkers to distinguish non-significant from significant prostate cancer
por: Frantzi, Maria, et al.
Publicado: (2019)

Urine peptidome analysis in cardiorenal syndrome reflects molecular processes
por: Petra, Eleni, et al.
Publicado: (2021)

Evaluation of the Zucker Diabetic Fatty (ZDF) Rat as a Model for Human Disease Based on Urinary Peptidomic Profiles
por: Siwy, Justyna, et al.
Publicado: (2012)

Urinary peptidomic profiles to address age-related disabilities: a prospective population study
por: Martens, Dries S, et al.
Publicado: (2021)

Comparison of Depletion Strategies for the Enrichment of Low-Abundance Proteins in Urine
por: Filip, Szymon, et al.
Publicado: (2015)

Validation of diagnostic nomograms based on CE–MS urinary biomarkers to detect clinically significant prostate cancer
por: Frantzi, Maria, et al.
Publicado: (2022)

Absolute quantification of endogenous angiotensin II levels in human plasma using ESI-LC-MS/MS
por: Schulz, Anna, et al.
Publicado: (2014)

A Model to Detect Significant Prostate Cancer Integrating Urinary Peptide and Extracellular Vesicle RNA Data
por: O’Connell, Shea P., et al.
Publicado: (2022)

Urine peptidome in combination with transcriptomics analysis highlights MMP7, MMP14 and PCSK5 for further investigation in chronic kidney disease
por: Petra, Eleni, et al.
Publicado: (2022)

Integrative analysis of extracellular and intracellular bladder cancer cell line proteome with transcriptome: improving coverage and validity of –omics findings
por: Latosinska, Agnieszka, et al.
Publicado: (2016)

CD99 and polymeric immunoglobulin receptor peptides deregulation in critical COVID‐19: A potential link to molecular pathophysiology?
por: Siwy, Justyna, et al.
Publicado: (2021)

Urinary peptides in heart failure: a link to molecular pathophysiology
por: He, Tianlin, et al.
Publicado: (2021)

Development of a MALDI MS‐based platform for early detection of acute kidney injury
por: Carrick, Emma, et al.
Publicado: (2016)

Comparative Analysis of Label-Free and 8-Plex iTRAQ Approach for Quantitative Tissue Proteomic Analysis
por: Latosinska, Agnieszka, et al.
Publicado: (2015)

Serum and urinary biomarkers of collagen type‐I turnover predict prognosis in patients with heart failure
por: He, Tianlin, et al.
Publicado: (2021)

Discovery, validation and sequencing of urinary peptides for diagnosis of liver fibrosis—A multicentre study
por: Bannaga, Ayman S., et al.
Publicado: (2020)

Promise and Implementation of Proteomic Prostate Cancer Biomarkers
por: Latosinska, Agnieszka, et al.
Publicado: (2018)

Prognosis and Personalized In Silico Prediction of Treatment Efficacy in Cardiovascular and Chronic Kidney Disease: A Proof-of-Concept Study
por: Jaimes Campos, Mayra Alejandra, et al.
Publicado: (2023)

PeptiCKDdb—peptide- and protein-centric database for the investigation of genesis and progression of chronic kidney disease
por: Krochmal, Magdalena, et al.
Publicado: (2016)

BcCluster: A Bladder Cancer Database at the Molecular Level
por: Bhat, Akshay, et al.
Publicado: (2016)

Urinary proteomics can define distinct diagnostic inflammatory arthritis subgroups
por: Siebert, Stefan, et al.
Publicado: (2017)

Analytical Performance of ELISA Assays in Urine: One More Bottleneck towards Biomarker Validation and Clinical Implementation
por: Chatziharalambous, Despina, et al.
Publicado: (2016)

Proteomics of Vitreous Humor of Patients with Exudative Age-Related Macular Degeneration
por: Koss, Michael Janusz, et al.
Publicado: (2014)

Urinary peptide-based classifier CKD273: towards clinical application in chronic kidney disease
por: Pontillo, Claudia, et al.
Publicado: (2017)

Proteomic Candidate Biomarkers of Drug-Induced Nephrotoxicity in the Rat
por: Rouse, Rodney, et al.
Publicado: (2012)

Proteomics as a Quality Control Tool of Pharmaceutical Probiotic Bacterial Lysate Products
por: Klein, Günter, et al.
Publicado: (2013)

An in-vitro assay using human spermatozoa to detect toxicity of biologically active substances
por: Vollmer, Tino, et al.
Publicado: (2019)

Plasma and Urinary Biomarkers Improve Prediction of Mortality through 1 Year in Intensive Care Patients: An Analysis from FROG-ICU
por: Davison, Beth A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_10je14fp5c80u0abpvd2kqnurp